GOVX - GeoVax Labs Inc

https://www.geovax.com

Momentum: Bearish

Recent News

GeoVax Labs ( GOVX ) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Commentary • 3 weeks, 4 days ago • score: 0.31

GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.

52W High

$3.94

52W Low

$0.43

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

3.57

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

10.63

EV/EBITDA (<8 favorable)

0.10

EV/Revenue (<3 favorable)

2.65

P/S (TTM) (<3 favorable)

2.88

P/B (<3 favorable)

6.27

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

6.07%

Institutions (25–75% balanced)

12.73%

Shares Outstanding

25,359,600

Float

19,929,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

6,143,000

Gross Profit (TTM)

-18,951,548

EPS (TTM)

-0.93

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-6.36%

ROE (TTM) (>15% strong)

-96.90%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

1.84

Momentum

Bearish momentum

Value

-0.0156

-0.0152

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025